<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tashiro S</submitter><funding>NIGMS NIH HHS</funding><pagination>2783-2793</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6370461</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(9)</volume><pubmed_abstract>DJ-1 is a Parkinson's disease associated protein endowed with enzymatic, redox sensing, regulatory, chaperoning, and neuroprotective activities. Although DJ-1 has been vigorously studied for the past decade and a half, its exact role in the progression of the disease remains uncertain. In addition, little is known about the spatiotemporal regulation of DJ-1, or the biochemical basis explaining its numerous biological functions. Progress has been hampered by the lack of inhibitors with precisely known mechanisms of action. Herein, we have employed biophysical methodologies and X-ray crystallography to identify and to optimize a family of compounds inactivating the critical Cys106 residue of human DJ-1. We demonstrate these compounds are potent inhibitors of various activities of DJ-1 in vitro and in cell-based assays. This study reports a new family of DJ-1 inhibitors with a defined mechanism of action, and contributes toward the understanding of the biological function of DJ-1.</pubmed_abstract><journal>ACS chemical biology</journal><pubmed_title>Discovery and Optimization of Inhibitors of the Parkinson's Disease Associated Protein DJ-1.</pubmed_title><pmcid>PMC6370461</pmcid><funding_grant_id>R01 GM111639</funding_grant_id><funding_grant_id>R01 GM115844</funding_grant_id><pubmed_authors>Caaveiro JMM</pubmed_authors><pubmed_authors>Nagatoishi S</pubmed_authors><pubmed_authors>Hoang QQ</pubmed_authors><pubmed_authors>Tamura Y</pubmed_authors><pubmed_authors>Nakakido M</pubmed_authors><pubmed_authors>Tsumoto K</pubmed_authors><pubmed_authors>Matsuda N</pubmed_authors><pubmed_authors>Liu D</pubmed_authors><pubmed_authors>Tanabe A</pubmed_authors><pubmed_authors>Tashiro S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Discovery and Optimization of Inhibitors of the Parkinson's Disease Associated Protein DJ-1.</name><description>DJ-1 is a Parkinson's disease associated protein endowed with enzymatic, redox sensing, regulatory, chaperoning, and neuroprotective activities. Although DJ-1 has been vigorously studied for the past decade and a half, its exact role in the progression of the disease remains uncertain. In addition, little is known about the spatiotemporal regulation of DJ-1, or the biochemical basis explaining its numerous biological functions. Progress has been hampered by the lack of inhibitors with precisely known mechanisms of action. Herein, we have employed biophysical methodologies and X-ray crystallography to identify and to optimize a family of compounds inactivating the critical Cys106 residue of human DJ-1. We demonstrate these compounds are potent inhibitors of various activities of DJ-1 in vitro and in cell-based assays. This study reports a new family of DJ-1 inhibitors with a defined mechanism of action, and contributes toward the understanding of the biological function of DJ-1.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Sep</publication><modification>2021-02-20T01:04:48Z</modification><creation>2019-03-26T22:54:23Z</creation></dates><accession>S-EPMC6370461</accession><cross_references><pubmed>30063823</pubmed><doi>10.1021/acschembio.8b00701</doi></cross_references></HashMap>